In February of 2025, the FDA declared a shortage of GLP-1 semaglutide, the active ingredient in Ozempic and Wegovy
Boye KS, Poon JL, Lando LF, Sapin H, Huh R, Wang M, Williamson S, Patel H (2024) Tirzepatide improved health-related quality of life compared with insulin lispro in basal insulin-treated adults with type 2 diabetes and inadequate glycaemic control: a randomised controlled phase 3b trial (SURPASS-6)
PlexusDx Precision Peptide Genetic Test identifies variants in GIPR (rs1800437), FTO (rs9939609), and MC4R (rs17782313)key genes regulating appetite, glucose homeostasis, and peptide-hormone signaling
This conservative approach provides maximum receptor recovery and works well for long-term users planning multiple cycles over a year or more
Riboflavin status in acute ischaemic stroke